1. Hu, Yifang, Zeng, Ni, Ge, Yaoqi, Jiang, Feng, Liu, Yun. 2022. Identification of the Shared Gene Signatures and Biological Mechanism in Type 2 Diabetes and Pancreatic Cancer. In Frontiers in endocrinology, 13, 847760. doi:10.3389/fendo.2022.847760. https://pubmed.ncbi.nlm.nih.gov/35432196/
2. Donato, Rosario, Sorci, Guglielmo, Giambanco, Ileana. 2017. S100A6 protein: functional roles. In Cellular and molecular life sciences : CMLS, 74, 2749-2760. doi:10.1007/s00018-017-2526-9. https://pubmed.ncbi.nlm.nih.gov/28417162/
3. Karimi, Nafiseh, Motovali-Bashi, Majid, Ghaderi-Zefrehei, Mostafa. 2023. Gene network reveals LASP1, TUBA1C, and S100A6 are likely playing regulatory roles in multiple sclerosis. In Frontiers in neurology, 14, 1090631. doi:10.3389/fneur.2023.1090631. https://pubmed.ncbi.nlm.nih.gov/36970516/
4. Filipek, Anna, Leśniak, Wiesława. 2020. S100A6 and Its Brain Ligands in Neurodegenerative Disorders. In International journal of molecular sciences, 21, . doi:10.3390/ijms21113979. https://pubmed.ncbi.nlm.nih.gov/32492924/
5. Hong, Bo, Zhang, Hui, Xiao, Yufei, Shen, Lingwei, Qian, Yun. 2023. S100A6 is a potential diagnostic and prognostic biomarker for human glioma. In Oncology letters, 26, 458. doi:10.3892/ol.2023.14045. https://pubmed.ncbi.nlm.nih.gov/37736555/
6. Guo, De-Zhen, Zhang, Xin, Zhang, Sen-Quan, Zhou, Jian, Huang, Ao. 2024. Single-cell tumor heterogeneity landscape of hepatocellular carcinoma: unraveling the pro-metastatic subtype and its interaction loop with fibroblasts. In Molecular cancer, 23, 157. doi:10.1186/s12943-024-02062-3. https://pubmed.ncbi.nlm.nih.gov/39095854/
7. Leśniak, Wiesława, Filipek, Anna. 2022. S100A6 as a Constituent and Potential Marker of Adult and Cancer Stem Cells. In Stem cell reviews and reports, 18, 2699-2708. doi:10.1007/s12015-022-10403-2. https://pubmed.ncbi.nlm.nih.gov/35796891/